{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:29:18Z","timestamp":1787934558070,"version":"build-2784847793"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.bone.2019.06.005","type":"journal-article","created":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T01:12:13Z","timestamp":1560042733000},"page":"367-375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Bone mineral density, structure, distribution and strength in men with prostate cancer treated with androgen deprivation therapy"],"prefix":"10.1016","volume":"127","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1815-0838","authenticated-orcid":false,"given":"Jack","family":"Dalla Via","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin M.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh L.","family":"Mundell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6977-4782","authenticated-orcid":false,"given":"Timo","family":"Rantalainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve F.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2019.06.005_bb0005","series-title":"Cancer in Australia 2017. Cancer Series No 101. Cat. No. CAN 100","author":"Australian Institute of Health and Welfare","year":"2017"},{"issue":"6","key":"10.1016\/j.bone.2019.06.005_bb0010","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.eururo.2012.02.054","article-title":"International variation in prostate cancer incidence and mortality rates","volume":"61","author":"Center","year":"2012","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.bone.2019.06.005_bb0015","first-page":"252","article-title":"Cancer treatment and survivorship statistics, 2014","volume":"64","author":"DeSantis","year":"2014","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bone.2019.06.005_bb0020","series-title":"NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer","author":"National Comprehensive Cancer Network","year":"2017"},{"issue":"4","key":"10.1016\/j.bone.2019.06.005_bb0025","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1200\/JCO.2013.49.5523","article-title":"Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: a systematic review","volume":"32","author":"Gardner","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bone.2019.06.005_bb0030","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.eururo.2008.10.008","article-title":"Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks","volume":"55","author":"Isbarn","year":"2009","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.bone.2019.06.005_bb0035","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.eururo.2014.07.010","article-title":"Adverse effects of androgen deprivation therapy and strategies to mitigate them","volume":"67","author":"Nguyen","year":"2015","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.bone.2019.06.005_bb0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/pcan.2016.69","article-title":"Lifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an update","volume":"20","author":"Owen","year":"2017","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"6","key":"10.1016\/j.bone.2019.06.005_bb0045","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2265.2002.01551.x","article-title":"Long-term effects of androgen deprivation therapy in prostate cancer patients","volume":"56","author":"Basaria","year":"2002","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"10.1016\/j.bone.2019.06.005_bb0050","first-page":"2787","article-title":"Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists","volume":"86","author":"Stoch","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bone.2019.06.005_bb0055","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0090-4295(99)00301-5","article-title":"Androgen deprivation therapy for prostate cancer results in significant loss of bone density","volume":"54","author":"Wei","year":"1999","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.bone.2019.06.005_bb0060","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.urology.2009.10.075","article-title":"Relationship between bone mineral density and androgen-deprivation therapy in Japanese prostate cancer patients","volume":"75","author":"Yuasa","year":"2010","journal-title":"Urology"},{"issue":"12","key":"10.1016\/j.bone.2019.06.005_bb0065","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1210\/jc.2005-0183","article-title":"Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer","volume":"90","author":"Greenspan","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2019.06.005_bb0070","doi-asserted-by":"crossref","DOI":"10.1177\/1179554917733449","article-title":"Effect of androgen deprivation therapy on bone mineral density in a prostate cancer cohort in New Zealand: a pilot study","volume":"11","author":"Wang","year":"2017","journal-title":"Clin. Med. Insights Oncol."},{"issue":"1","key":"10.1016\/j.bone.2019.06.005_bb0075","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1464-410X.2008.07539.x","article-title":"Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer","volume":"102","author":"Galv\u00e3o","year":"2008","journal-title":"BJU Int."},{"issue":"8","key":"10.1016\/j.bone.2019.06.005_bb0080","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/cncr.21381","article-title":"Changes in bone mineral density and body composition during initial and long-term gonadotropin-releasing hormone agonist treatment for prostate carcinoma","volume":"104","author":"Lee","year":"2005","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.bone.2019.06.005_bb0085","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1464-410X.2009.08483.x","article-title":"Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values","volume":"104","author":"Wadhwa","year":"2009","journal-title":"BJU Int."},{"issue":"2","key":"10.1016\/j.bone.2019.06.005_bb0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11914-006-0002-9","article-title":"Bone geometry and skeletal fragility","volume":"4","author":"Bouxsein","year":"2006","journal-title":"Curr. Osteoporos. Rep."},{"issue":"1","key":"10.1016\/j.bone.2019.06.005_bb0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40279-013-0100-7","article-title":"Bone quality: the determinants of bone strength and fragility","volume":"44","author":"Fonseca","year":"2014","journal-title":"Sports Med."},{"issue":"12","key":"10.1016\/j.bone.2019.06.005_bb0100","doi-asserted-by":"crossref","first-page":"E456","DOI":"10.1210\/jc.2010-0902","article-title":"Structural decay of bone microarchitecture in men with prostate cancer treated with androgen deprivation therapy","volume":"95","author":"Hamilton","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2019.06.005_bb0105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1469-7580.2003.00212.x","article-title":"Intrapopulation variability in mineralization density at the human femoral mid-shaft","volume":"203","author":"Goldman","year":"2003","journal-title":"J. Anat."},{"issue":"3","key":"10.1016\/j.bone.2019.06.005_bb0110","first-page":"243","article-title":"An open source approach for regional cortical bone mineral density analysis","volume":"11","author":"Rantalainen","year":"2011","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"9727","key":"10.1016\/j.bone.2019.06.005_bb0115","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0140-6736(10)60320-0","article-title":"Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study","volume":"375","author":"Zebaze","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bone.2019.06.005_bb0120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1469-7580.2005.00384.x","article-title":"Regional variation of intracortical porosity in the midshaft of the human femur: age and sex differences","volume":"206","author":"Thomas","year":"2005","journal-title":"J. Anat."},{"issue":"2","key":"10.1016\/j.bone.2019.06.005_bb0125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1469-7580.2005.00385.x","article-title":"Relationships among microstructural properties of bone at the human midshaft femur","volume":"206","author":"Goldman","year":"2005","journal-title":"J. Anat."},{"issue":"3","key":"10.1016\/j.bone.2019.06.005_bb0130","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.bone.2009.05.025","article-title":"The degree and distribution of cortical bone mineralization in the human femoral shaft change with age and sex in a microradiographic study","volume":"45","author":"Bergot","year":"2009","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2019.06.005_bb0135","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1148\/radiology.217.1.r00se11179","article-title":"CT of the middiaphyseal femur: cortical bone mineral density and relation to porosity","volume":"217","author":"Bousson","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.bone.2019.06.005_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.3746","article-title":"Relationship between sex steroids and deterioration of bone microarchitecture in older men: the prospective STRAMBO Study","author":"Piot","year":"2019","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2019.06.005_bb0145","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1186\/s13063-017-2185-z","article-title":"Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial","volume":"18","author":"Owen","year":"2017","journal-title":"Trials"},{"key":"10.1016\/j.bone.2019.06.005_bb0150","series-title":"ACSM's Resource Manual for Guidelines for Exercise Testing and Prescription","author":"American College of Sports Medicine","year":"2010"},{"issue":"8","key":"10.1016\/j.bone.2019.06.005_bb0155","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","article-title":"The diagnosis of osteoporosis","volume":"9","author":"Kanis","year":"1994","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.bone.2019.06.005_bb0160","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"issue":"6","key":"10.1016\/j.bone.2019.06.005_bb0165","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.bone.2010.08.023","article-title":"BoneJ: free and extensible bone image analysis in ImageJ","volume":"47","author":"Doube","year":"2010","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bone.2019.06.005_bb0170","first-page":"401","article-title":"Strength indices from pQCT imaging predict up to 85% of variance in bone failure properties at tibial epiphysis and diaphysis","volume":"8","author":"Kontulainen","year":"2008","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"3","key":"10.1016\/j.bone.2019.06.005_bb0175","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jocd.2010.05.005","article-title":"Evidence for enhanced characterization of cortical bone using novel pQCT shape software","volume":"13","author":"Laskey","year":"2010","journal-title":"J. Clin. Densitom."},{"issue":"2","key":"10.1016\/j.bone.2019.06.005_bb0180","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00223-013-9803-x","article-title":"Standardizing evaluation of pQCT image quality in the presence of subject movement: qualitative versus quantitative assessment","volume":"94","author":"Blew","year":"2014","journal-title":"Calcif. Tissue Int."},{"issue":"2","key":"10.1016\/j.bone.2019.06.005_bb0185","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jocd.2017.07.002","article-title":"Please don't move\u2014evaluating motion artifact from peripheral quantitative computed tomography scans using textural features","volume":"21","author":"Rantalainen","year":"2018","journal-title":"J. Clin. Densitom."},{"issue":"3","key":"10.1016\/j.bone.2019.06.005_bb0190","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jocd.2011.05.002","article-title":"Peripheral quantitative computed tomography: optimization of reproducibility measures of bone density, geometry, and strength at the radius and tibia","volume":"14","author":"Rinaldi","year":"2011","journal-title":"J. Clin. Densitom."},{"issue":"4","key":"10.1016\/j.bone.2019.06.005_bb0195","first-page":"438","article-title":"Reliability of upper-limb diaphyseal mineral and soft-tissue measurements using peripheral Quantitative Computed Tomography (pQCT)","volume":"18","author":"Jenkins","year":"2018","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"33","key":"10.1016\/j.bone.2019.06.005_bb0200","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/00005768-200107000-00010","article-title":"CHAMPS physical activity questionnaire for older adults: outcomes for interventions","author":"Stewart","year":"2001","journal-title":"Med. Sci. Sports Exerc."},{"issue":"22","key":"10.1016\/j.bone.2019.06.005_bb0205","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1002\/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F","article-title":"Sympercents: symmetric percentage differences on the 100 loge scale simplify the presentation of log transformed data","volume":"19","author":"Cole","year":"2000","journal-title":"Stat. Med."},{"issue":"5","key":"10.1016\/j.bone.2019.06.005_bb0210","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0022-5347(05)00999-7","article-title":"Bone mineral density changes in patients with prostate cancer during the first 2 years of androgen suppression","volume":"175","author":"Morote","year":"2006","journal-title":"J. Urol."},{"issue":"3","key":"10.1016\/j.bone.2019.06.005_bb0215","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.steroids.2008.10.003","article-title":"Androgens and bone","volume":"74","author":"Clarke","year":"2009","journal-title":"Steroids"},{"issue":"12","key":"10.1016\/j.bone.2019.06.005_bb0220","first-page":"4358","article-title":"Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism","volume":"81","author":"Katznelson","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"13","key":"10.1016\/j.bone.2019.06.005_bb0225","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1056\/NEJMoa010845","article-title":"Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer","volume":"345","author":"Smith","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bone.2019.06.005_bb0230","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1210\/jc.2002-021429","article-title":"Deterioration of trabecular architecture in hypogonadal men","volume":"88","author":"Benito","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.bone.2019.06.005_bb0235","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1359\/JBMR.050606","article-title":"Effect of testosterone replacement on trabecular architecture in hypogonadal men","volume":"20","author":"Benito","year":"2005","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bone.2019.06.005_bb0240","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jamainternmed.2016.9539","article-title":"Effect of testosterone treatment on volumetric bone density and strength in older men with low testosterone: a controlled clinical trial","volume":"177","author":"Snyder","year":"2017","journal-title":"JAMA Intern. Med."},{"issue":"1","key":"10.1016\/j.bone.2019.06.005_bb0245","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1152\/physrev.00033.2015","article-title":"Estrogens and androgens in skeletal physiology and pathophysiology","volume":"97","author":"Almeida","year":"2017","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.bone.2019.06.005_bb0250","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/jbmr.1771","article-title":"Vertebral fractures and trabecular microstructure in men with prostate cancer on androgen deprivation therapy","volume":"28","author":"Greenspan","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"9320","key":"10.1016\/j.bone.2019.06.005_bb0255","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(02)08706-8","article-title":"Pathogenesis of bone fragility in women and men","volume":"359","author":"Seeman","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bone.2019.06.005_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ar.1092190104","article-title":"Bone \u201cmass\u201d and the \u201cmechanostat\u201d: a proposal","volume":"219","author":"Frost","year":"1987","journal-title":"Anat. Rec."},{"issue":"12","key":"10.1016\/j.bone.2019.06.005_bb0265","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1210\/jc.2003-031719","article-title":"Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study","volume":"89","author":"Araujo","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bone.2019.06.005_bb0270","doi-asserted-by":"crossref","first-page":"R305","DOI":"10.1677\/ERC-10-0187","article-title":"An update on androgen deprivation therapy for prostate cancer","volume":"17","author":"Sharifi","year":"2010","journal-title":"Endocr. Relat. Cancer"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219302352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219302352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:48:17Z","timestamp":1757612897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328219302352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":54,"alternative-id":["S8756328219302352"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2019.06.005","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone mineral density, structure, distribution and strength in men with prostate cancer treated with androgen deprivation therapy","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2019.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}